Indicateurs
1 Consultations de la notice
- Titre
- A Randomized, Placebo‐Controlled Trial Evaluating Effects of Lebrikizumab on Airway Eosinophilic Inflammation and Remodeling in Uncontrolled Asthma (CLAVIER)
- Créateurs - sans rôle
- Cary D. Austin - Genentech, IncMelissa Gonzalez Edick - Genentech, IncRonald E. Ferrando - Genentech, IncMargaret Solon - Genentech, IncMiriam Baca - Genentech, IncKathryn Mesh - Genentech, IncPeter Bradding - University of LeicesterGail M. Gauvreau - McMaster UniversityKaharu Sumino - Washington University School of MedicineMark Fitzgerald - University of British ColumbiaEliott Israel - Brigham and Women’s HospitalLeif Bjermer - Skåne University HospitalArnaud Bourdin - CHU MontpellierJoseph R. Arron - Genentech, IncDavid F. Choy - Genentech, IncJulie K. Olsson - Genentech, IncFrancis D. Abreu - Genentech, IncMonet D. Howard - Genentech, IncKit D. Wong - Genentech, IncFang D. Cai - Genentech, IncKun D. Peng - Genentech, IncWendy S. Putman - Genentech, IncCécile T. J. Holweg - Genentech, IncJohn G. Matthews - Genentech, IncMonica Kraft - University of ArizonaPrescott G. Woodruff - University of California San Francisco Medical Center
- Détails de publication
- The FASEB journal, Vol.34(S1), pp.1-1
- Nombre de pages
- 1
- Identifiants
- 99158807309311
- Unité académique
- Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
- Langue
- English
- Type de ressource
- Journal article